Created at	Source	Raw Value	Validated value
May 25, 2022, 10:30 a.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "BSC", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "BSC;Ravulizumab", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}]	[{"arm_notes": "", "treatment_id": 1065, "treatment_name": "Ravulizumab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
Oct. 26, 2020, 11:31 p.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Best Supportive Care", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Best Supportive Care;Ravulizumab", "treatment_type": "Other;Biological", "pharmacological_treatment": "Non pharmacological treatment"}]	[{"arm_notes": "Ravulizumab/Other Names: Ultomiris, ALXN1210", "treatment_id": 1065, "treatment_name": "Ravulizumab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]